Lo Re and colleagues delineated a plausible link between the stem cell regulatory properties of macroH2A1, a variant of the histone H2A and epigenetic modifier of stem-cell function, and the development of CSCs in HCC [81]. The gene discussed is MACROH2A1; the disease is hepatocellular carcinoma.